184 related articles for article (PubMed ID: 26500885)
21. Different clinical importance of FLT3 internal tandem duplications in AML according to FAB classification: possible existence of distinct leukemogenesis involving monocyte differentiation pathway.
Koh Y; Park J; Ahn KS; Kim I; Bang SM; Lee JH; Yoon SS; Soon Lee D; Yiul Lee Y; Park S; Kim BK
Ann Hematol; 2009 Nov; 88(11):1089-97. PubMed ID: 19296110
[TBL] [Abstract][Full Text] [Related]
22. Bone Marrow Clonogenic Myeloid Progenitors from
Guardia RD; González-Silva L; López-Millán B; Rodríguez-Sevilla JJ; Baroni ML; Bueno C; Anguita E; Vives S; Palomo L; Lapillonne H; Varela I; Menendez P
Genes (Basel); 2020 Jan; 11(1):. PubMed ID: 31936647
[TBL] [Abstract][Full Text] [Related]
23. Interplay of protein misfolding pathway and unfolded-protein response in acute promyelocytic leukemia.
Khan M
Expert Rev Proteomics; 2010 Aug; 7(4):591-600. PubMed ID: 20653512
[TBL] [Abstract][Full Text] [Related]
24. Overexpression and constitutive activation of FLT3 induces STAT5 activation in primary acute myeloid leukemia blast cells.
Spiekermann K; Bagrintseva K; Schwab R; Schmieja K; Hiddemann W
Clin Cancer Res; 2003 Jun; 9(6):2140-50. PubMed ID: 12796379
[TBL] [Abstract][Full Text] [Related]
25. NT1721, a novel epidithiodiketopiperazine, exhibits potent in vitro and in vivo efficacy against acute myeloid leukemia.
Kowolik CM; Lin M; Xie J; Overman LE; Horne DA
Oncotarget; 2016 Dec; 7(52):86186-86197. PubMed ID: 27863389
[TBL] [Abstract][Full Text] [Related]
26. CDC25A governs proliferation and differentiation of FLT3-ITD acute myeloid leukemia.
Bertoli S; Boutzen H; David L; Larrue C; Vergez F; Fernandez-Vidal A; Yuan L; Hospital MA; Tamburini J; Demur C; Delabesse E; Saland E; Sarry JE; Galcera MO; Mansat-De Mas V; Didier C; Dozier C; Récher C; Manenti S
Oncotarget; 2015 Nov; 6(35):38061-78. PubMed ID: 26515730
[TBL] [Abstract][Full Text] [Related]
27. Live kinase B1 maintains CD34
Wang H; Wang X; Xin N; Qi L; Liao A; Yang W; Liu Z; Zhao C
Mol Cell Biochem; 2017 Oct; 434(1-2):25-32. PubMed ID: 28397012
[TBL] [Abstract][Full Text] [Related]
28. Acquired expression of osteopontin selectively promotes enrichment of leukemia stem cells through AKT/mTOR/PTEN/β-catenin pathways in AML cells.
Mohammadi S; Ghaffari SH; Shaiegan M; Zarif MN; Nikbakht M; Akbari Birgani S; Alimoghadam K; Ghavamzadeh A
Life Sci; 2016 May; 152():190-8. PubMed ID: 27063991
[TBL] [Abstract][Full Text] [Related]
29. Transcriptomic Analysis Identifies RNA Binding Proteins as Putative Regulators of Myelopoiesis and Leukemia.
Saha S; Murmu KC; Biswas M; Chakraborty S; Basu J; Madhulika S; Kolapalli SP; Chauhan S; Sengupta A; Prasad P
Front Oncol; 2019; 9():692. PubMed ID: 31448224
[TBL] [Abstract][Full Text] [Related]
30.
Nguyen CH; Grandits AM; Vassiliou GS; Staber PB; Heller G; Wieser R
Biomedicines; 2020 Sep; 8(10):. PubMed ID: 32998330
[No Abstract] [Full Text] [Related]
31. Human FLT3/FLK2 receptor tyrosine kinase is expressed at the surface of normal and malignant hematopoietic cells.
Rosnet O; Bühring HJ; Marchetto S; Rappold I; Lavagna C; Sainty D; Arnoulet C; Chabannon C; Kanz L; Hannum C; Birnbaum D
Leukemia; 1996 Feb; 10(2):238-48. PubMed ID: 8637232
[TBL] [Abstract][Full Text] [Related]
32. The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients.
Hoang VT; Buss EC; Wang W; Hoffmann I; Raffel S; Zepeda-Moreno A; Baran N; Wuchter P; Eckstein V; Trumpp A; Jauch A; Ho AD; Lutz C
Int J Cancer; 2015 Aug; 137(3):525-36. PubMed ID: 25545165
[TBL] [Abstract][Full Text] [Related]
33. Fetal and neonatal hematopoietic progenitors are functionally and transcriptionally resistant to
Porter SN; Cluster AS; Yang W; Busken KA; Patel RM; Ryoo J; Magee JA
Elife; 2016 Nov; 5():. PubMed ID: 27879203
[TBL] [Abstract][Full Text] [Related]
34. Adrenomedullin Expression Characterizes Leukemia Stem Cells and Associates With an Inflammatory Signature in Acute Myeloid Leukemia.
Simonetti G; Angeli D; Petracci E; Fonzi E; Vedovato S; Sperotto A; Padella A; Ghetti M; Ferrari A; Robustelli V; Di Liddo R; Conconi MT; Papayannidis C; Cerchione C; Rondoni M; Astolfi A; Ottaviani E; Martinelli G; Gottardi M
Front Oncol; 2021; 11():684396. PubMed ID: 34150648
[TBL] [Abstract][Full Text] [Related]
35. Diminished AHR Signaling Drives Human Acute Myeloid Leukemia Stem Cell Maintenance.
Ly M; Rentas S; Vujovic A; Wong N; Moreira S; Xu J; Holzapfel N; Bhatia S; Tran D; Minden MD; Draper JS; Hope KJ
Cancer Res; 2019 Nov; 79(22):5799-5811. PubMed ID: 31519687
[TBL] [Abstract][Full Text] [Related]
36. Effects of FLT3 ligand on proliferation and survival of myeloid leukemia cells.
Drexler HG; Meyer C; Quentmeier H
Leuk Lymphoma; 1999 Mar; 33(1-2):83-91. PubMed ID: 10194124
[TBL] [Abstract][Full Text] [Related]
37. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell.
Bonnet D; Dick JE
Nat Med; 1997 Jul; 3(7):730-7. PubMed ID: 9212098
[TBL] [Abstract][Full Text] [Related]
38. FLT3 receptor expression on the surface of normal and malignant human hematopoietic cells.
Turner AM; Lin NL; Issarachai S; Lyman SD; Broudy VC
Blood; 1996 Nov; 88(9):3383-90. PubMed ID: 8896403
[TBL] [Abstract][Full Text] [Related]
39. ELMO1 is upregulated in AML CD34+ stem/progenitor cells, mediates chemotaxis and predicts poor prognosis in normal karyotype AML.
Capala ME; Vellenga E; Schuringa JJ
PLoS One; 2014; 9(10):e111568. PubMed ID: 25360637
[TBL] [Abstract][Full Text] [Related]
40. CD117/CD34 expression in leukemic blasts.
Wells SJ; Bray RA; Stempora LL; Farhi DC
Am J Clin Pathol; 1996 Aug; 106(2):192-5. PubMed ID: 8712172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
